These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Maternal-fetal transport of hypoglycaemic drugs. Garcia-Bournissen F; Feig DS; Koren G Clin Pharmacokinet; 2003; 42(4):303-13. PubMed ID: 12648023 [TBL] [Abstract][Full Text] [Related]
54. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies. Roth S; Abernathy MP; Lee WH; Pratt L; Denne S; Golichowski A; Pescovitz OH J Soc Gynecol Investig; 1996; 3(2):78-84. PubMed ID: 8796812 [TBL] [Abstract][Full Text] [Related]
55. Hyperinsulinemia and macrosomia. Schwartz R N Engl J Med; 1990 Aug; 323(5):340-2. PubMed ID: 2195349 [No Abstract] [Full Text] [Related]
56. [Fetal macrosomia is still a great problem of maternal diabetes]. Teramo K Duodecim; 1998; 114(21):2253-9. PubMed ID: 11757116 [No Abstract] [Full Text] [Related]
57. Transplacental passage of insulin. N Engl J Med; 1991 Jan; 324(3):198-9. PubMed ID: 1984201 [No Abstract] [Full Text] [Related]
58. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia. Menon RK; Cohen RM; Sperling MA; Cutfield WS; Mimouni F; Khoury JC N Engl J Med; 1990 Aug; 323(5):309-15. PubMed ID: 2195347 [TBL] [Abstract][Full Text] [Related]